SOC-1: Overall Survival Final Results With Drs. Rongyu Zang And Yulian Chen IJGC podcast

Contenido proporcionado por BMJ Group. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente BMJ Group o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

IJGC Podcast »
SOC-1: Overall Survival Final Results with Drs. Rongyu Zang and Yulian Chen

3d ago 32:24

MP3•Episodio en casa

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Rongyu Zang and Yulian Chen to discuss the SOC-1 trial. Dr. Rongyu Zang is the Director of the Department of Gynecologic Oncology, Fudan University Zhongshan Hospital, & Institute for Ovarian Cancer, Fudan University and is the Principal investigator of the SOC-1 and SUNNY trials. Dr. Yulian Chen is an Attending Physician at the Department of Gynecologic Oncology, Fudan University Zhongshan Hospital.

Highlights:

The SOC-1 trial concluded that in patients with platinum-sensitive, relapsed ovarian cancer, surgery did not increase overall survival in the intention-to-treat population, but resulted in a prolongation of survival after adjustment of crossover.
Surgery may provide an obviously higher proportion of long-term relapse-free survivors than chemotherapy alone.
An active preoperative evaluation for all patients with platinum-sensitive first relapsed ovarian cancer is suggested in specialized centers.

380 episodios

#BMJ Group #Pedro Ramirez #Fitness #Medicine